Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GSK image

GSK tops drug approval rates

March 7, 2014
Medical Communications, Sales and Marketing FDA, GSK, J&J, JJ, Merck, Sanofi, ep, evaluate pharma, lilly, nme

GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …

News
GSK sign

GSK submits new Promacta licence

March 3, 2014
Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag

GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …

News
Witty image

GSK’s Witty loses bonus over China scandal

February 28, 2014
Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew

GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …

News
GSK image

CHMP breathes new life into GSK, Teva and Novartis

February 24, 2014
Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro

The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …

News
gsk image

GSK/Theravance lung drug bags CHMP approval

February 21, 2014
Sales and Marketing CHMP, COPD, GSK, Theravance, anoro

The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …

News
gsk image

GSK starts rare blood trial

February 18, 2014
Research and Development, Sales and Marketing GSK, blood, mepolizumab

GlaxoSmithKline has begun a Phase III study to look at mepolizumab in a rare condition characterised by vasculitis – widespread …

News
gsk_through_window

Pharma’s reputation ‘getting worse’

February 17, 2014
Medical Communications, Sales and Marketing GSK, Gilead, Pfizer, ViiV, patientview, pharma, reputation

The pharma industry’s reputation is getting worse – at least, in the eyes of 800 patient groups – according to …

News
gsk image

GSK to make ‘fundamental changes’

February 6, 2014
Sales and Marketing China, GSK, Tafinlar, Witty, q4, results

GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …

News
National Institutes of Health image

Drug giants team up for Alzheimer’s

February 5, 2014
Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer

The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …

News
GSK vaccines

GSK halts chickenpox vaccines over quality concerns

January 29, 2014
Manufacturing and Production, Sales and Marketing Boostrix-Polio, GSK, Varilrix, chickenpox, vaccines

GlaxoSmithKline has suspended worldwide distribution of two chickenpox vaccines after production standards were not met at one of its facilities …

News

GSK has Tafinlar ‘breakthrough’

January 15, 2014
Sales and Marketing Cancer, FDA, GSK, NSCLC, Tafinlar

GlaxoSmithKline is on a roll, with its cancer drug Tafinlar given breakthrough therapy designation by the FDA in lung cancer …

News
gsk image

FDA approves GSK cancer combo

January 14, 2014
Research and Development, Sales and Marketing FDA, GSK, Tafinlar, mekinist

US regulators have shown the green light to a combination of two GlaxoSmithKline skin cancer drugs, Mekinist and Tafinlar, to …

News
gsk image

GSK makes imaging deal

January 14, 2014
Manufacturing and Production, Sales and Marketing 3D, GSK, imaging, npl

GlaxoSmithKline has signed a deal with the National Physical Laboratory (NPL) to develop an imaging system which can show for …

News
GSK image

GSK and Sanofi expand transparency

January 6, 2014
Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency

GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …

News
gsk image

GSK sells off non-core assets

January 6, 2014
Sales and Marketing GSK, Suntory, aspen, lucozade, ribena

GlaxoSmithKline has completed the offloading of several of its non-core assets in moves which stand to net the pharma manufacturer …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025